No Data
No Data
Individual investor and limited teahouse Tamasuke: Evaluate the information war in the US presidential election! Now, focus only on strong stocks [FISCO Social Reporter]
The following is a comment written by individual investor Mr. Yugen Tei, a Fisco Social Reporter (Blog: Profitable Stock Information 'The Cat Husband's Stocks Know No Bounds'). At Fisco, we strive to actively collaborate with individuals who proactively provide information, and to disseminate a wider range of information to investors. -----------*Written at 12:00 on August 26, 2024, it goes without saying that the result of the U.S. presidential election will have a significant impact on the Japanese stock market. August 2
Ranking of volume change rate (10:00) - Yoshimura Food, Secure, and others ranked.
* In the volume change rate ranking, you can understand the interest of market participants, such as trend of speculation, by comparing the volume of the latest 5-day average with the volume on the delivery day. * Volume Change Rate Top [as of 10:32 on August 20] (comparison of latest 5-day average volume) Code Company Name Volume 5-day Average Volume Volume Change Rate Stock Price Change Rate <4264> Secure 452,800 140,555.96 209.92% 0.06
Stocks that moved the previous day, part 1: 7&iHD, Shionogi & Co., Ltd., Double A, etc.
Stock name <code>19 closing price ⇒ comparison with the previous dayAsuka Pharmaceutical HD <4886> 2,309 + 21 Obtained approval for manufacturing and selling oral contraceptive drospirenone in South Korea. In the afternoon, the increase narrowed. 7&iHD <3382> 2,161 + 400 Acquired proposal reported from Canada's largest convenience store chain, Alimentation Couche-Tard. Renascience <4889> 353 + 14 Clinical performance tests of AI to predict insulin dosage for diabetes patients have started. Economic <3802>
Piara, TREHD, Sumitomo Pharma, etc.
<4886> Asuka Pharmaceutical HD 2309 +21 continued to rise. After the close of last week's trading, a subsidiary of Asuka Pharmaceutical announced that its oral contraceptive containing drospirenone as the sole active ingredient had been granted manufacturing and sales approval by Hyundai Pharm, its licensing partner in South Korea, becoming a factor in buying caution. Asuka Pharmaceutical has applied for manufacturing and sales approval in Japan in June 24. <7044> Piala 274 +41 soared rapidly.
Zukawa Electric continues to rise for 5 business days and captures the 25-day moving average.
Continuing rise for 5 business days. After breaking through the 200-day moving average, the rebound trend has strengthened and it has caught up with the 25-day moving average. Although it is under the cloud in Ichimoku Kinko Hyo, after breaking through the conversion line, it is functioning as resistance, and it has risen above the standard line and is approaching the lower limit of the cloud. Since the twist of the cloud will occur next month, it is likely to shift towards a stance aimed at breaking the cloud.
Hot stocks digest (morning): Sumitomo Pharmaceuticals, Double A, Pan Pacific HD, etc.
MH Group <9439>: 196 yen (-7 yen) significant decline. They announced their financial results for the year ending June 24th after the end of the previous week's trading. Operating profit was 0.023 billion yen, a 57.5% decrease from the previous year. It seems to have been disappointed that it fell to a deficit, about 64% lower than the previous estimate of 0.065 billion yen. This is due to the PB product sales in the BS salon operating business being below expectations, as well as an increase in cost of sales and personnel expenses. Operating profit for the year ending June 25th is 0.03 billion yen, up 29.6% from the previous year.
No Data